Latest News

First human trials show non-invasive diagnosis of bone diseases possible

New research carried out within the Central Laser Facility (CLF) at the Research Complex at Harwell in collaboration with UCL and the Royal National Orthopaedic Hospital (RNOH) in Stanmore could lead to the early diagnosis of debilitating conditions such as ‘brittle bone’ and osteoporosis.  Pavel Matousek and his team have detected, for the first time, a ‘brittle bone’ disease known as Osteogenesis Imperfecta (OI) by simply scanning patient’s limbs using harmless laser light. They used Spatially Offset Raman Spectroscopy (SORS), a new concept developed earlier within the CLF.  For more information click here

The Research Complex at Harwell (RCaH) is a new, multidisciplinary laboratory that provides facilities for researchers to undertake new and cutting edge scientific research in both life and physical sciences and the interface between them. It is located on the Rutherford Appleton Laboratory (RAL) site on the Harwell Science and Innovation Campus, adjacent to Diamond, the new third generation Synchrotron Radiation (SR) source. It is also close to other leading facilities on the campus: the ISIS neutron source, Central Laser Facility, Membrane Protein Laboratory, MRC Mammalian Genetics Unit and Mary Lyon Centre, and a Biological Solid State NMR Facility.

It is open, on a competitive basis, to research teams from UK universities, as well as to Diamond and RAL staff. The MRC is leading the project on behalf of RCUK, in partnership with BBSRC, EPSRC, NERC, STFC and Diamond.